Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Capstan Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Capstan Therapeutics

Capstan Therapeutics

Capstan Therapeutics: Pioneering precise in vitro and in vivo cell engineering for unmet medical needs.

HQ
San Diego, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Capstan Therapeutics was founded with the mission to advance precision in vitro and in vivo cell engineering, aiming to develop therapeutics for a wide range of diseases that currently have unmet or underserved clinical needs. The company focuses on innovative cell engineering techniques to create targeted treatments, leveraging cutting-edge technologies to address complex medical challenges. Their market focus includes developing therapies for conditions such as cardiac fibrosis and enhancing CAR T cell therapies.

Notable affiliated individuals include leading scientists and industry experts who contribute to Capstan's pioneering research. The company has garnered attention through significant publications in esteemed journals like Science and The New England Journal of Medicine. Key achievements include advancements in mRNA delivery for hematopoietic stem cell modification and CAR T cell therapies. Capstan Therapeutics is making a substantial impact by pushing the boundaries of cell engineering to offer new hope for patients with critical medical needs.

Capstan Therapeutics - Similar Companies

Stemson Therapeutics logo

Stemson Therapeutics

stemsontx.com

Capsida Biotherapeutics logo

Capsida Biotherapeutics

capsida.com

Capstan Medical logo

Capstan Medical

capstanmedical.com

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

Cartesian Therapeutics logo

Cartesian Therapeutics

Century Therapeutics logo

Century Therapeutics

centurytx.com

Stellanova Therapeutics logo

Stellanova Therapeutics

stellanovatx.com

AlphaStem logo

AlphaStem

alpha-stim.com

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Garuda Therapeutics logo

Garuda Therapeutics

garudatx.com

Vita Therapeutics logo

Vita Therapeutics

Cargene logo

Cargene

cargene.com

Capacity Bio logo

Capacity Bio

capacitybio.com

Carmine Therapeutics logo

Carmine Therapeutics

Capstan Therapeutics - Quick Facts

Who are Capstan Therapeutics' competitors?

Companies similar to Capstan Therapeutics include Stemson Therapeutics, Capsida Biotherapeutics, Capstan Medical and Cell BioEngines.

When was Capstan Therapeutics founded?

Capstan Therapeutics was founded in 2021.

Where is Capstan Therapeutics' headquarters located?

Capstan Therapeutics' headquarters is located in San Diego, CA, US.

When was Capstan Therapeutics' last funding round?

Capstan Therapeutics' most recent funding round was for $102M (USD) in September 2022.

How much has Capstan Therapeutics raised to-date?

As of Sep 14, 2022, Capstan Therapeutics has raised a total of $165M (USD).

How many employees does Capstan Therapeutics have?

Capstan Therapeutics has 175 employees as of Feb 4, 2024.

Capstan Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Cell Therapies
  • Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified